New Additions to TrumpRx.gov

President Donald Trump announced a significant expansion of his administration’s efforts to provide Americans with access to discounted prescription medications. In a post on Truth Social, Trump revealed that the government-backed website TrumpRx.gov has added 160 new prescription drugs, raising the total number of discounted medications available through the initiative to over 800.

“I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” Trump stated. He emphasized that “TrumpRx.gov will now provide clear, transparent, and DISCOUNTED offerings for FOUR OUT OF FIVE of every prescription filled by Americans.”

Addressing High Prescription Drug Costs

Trump first unveiled this initiative in February, contending that Americans have historically paid more for prescription drugs than consumers in many other countries. The program was launched following agreements with 16 major pharmaceutical companies under “most-favored-nation” pricing arrangements.

Under these agreements, participating drug manufacturers were granted tariff-related exemptions in exchange for agreeing to lower prices for specific medications and extend discounted pricing to eligible cash-paying consumers through the TrumpRx program.

Participating Pharmaceutical Companies

Notable companies such as Eli Lilly and Novo Nordisk are participating in the program, which includes reductions in prices for popular GLP-1 weight-loss medications. The administration has also highlighted discounts on a variety of other products, including inhalers, HIV treatments, diabetes medications, and fertility drugs.

User-Friendly Experience at TrumpRx.gov

The website TrumpRx.gov allows users to search for discounted medications, check estimated savings, and generate coupons for participating prescriptions, making it easier for Americans to access affordable healthcare solutions.

A Continuation of Efforts to Lower Drug Prices

Trump’s initiative builds on the administration’s earlier efforts to reduce prescription drug costs during his first term. “I was proud to make history during my First Term when we lowered drug prices, even if by a tiny percentage, because this amounted to a HUGE change compared to other presidents only raising drug prices, endlessly and significantly, every year,” Trump remarked.

He continued, “Then, during my Second Term, I decided to go BIG with Most Favored Nations Pricing — that is to say, we pay no more or, ideally, less than any other country for the same exact drug. Now we are cutting prices, and cutting them by a LOT, sometimes by 400 or 500 or 600 Percent!”

Significant Savings for Patients

According to Trump, the program has already yielded considerable savings for consumers. “These Most Favored Nations Deals have already, in fact, saved American patients over 400 million dollars since the launch of TrumpRx.gov,” he stated, indicating the financial impact of the initiative.

The president also asserted that the use of tariffs has been instrumental in securing these advantageous pricing agreements. “Of course, Most Favored Nations would not be possible without my use of TARIFFS, which are getting other countries to ‘pay up’ instead of relying on American patients getting ripped off, as they were for decades until I ordered an immediate ‘stop’ to this very unfair and, frankly, foolish situation,” Trump concluded.

“This is all great news, and I have instructed my administration to secure more Most Favored Nations Deals, more partnerships, and lower prices for every American patient,” he added.